We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

32 hedge funds and large institutions have $19.6M invested in Annovis Bio in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.3% less ownership

Funds ownership: 14.08% → 13.78% (-0.3%)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

16% less funds holding

Funds holding: 38 → 32 (-6)

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

46% less capital invested

Capital invested by funds: $36.2M → $19.6M (-$16.6M)

Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
9
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$3.02M
2
BlackRock
BlackRock
New York
+$1.14M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$866K
4
Citadel Advisors
Citadel Advisors
Florida
+$565K
5
BAM
Blueshift Asset Management
New Jersey
+$423K

Top Sellers

Rank Fund Capital Flow
1
Voloridge Investment Management
Voloridge Investment Management
Florida
-$2.21M
2
ACM
AIGH Capital Management
Maryland
-$2.11M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.18M
4
WVP
Worth Venture Partners
New Jersey
-$631K
5
VF
Virtu Financial
New York
-$367K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$44K +$53.8K +2,088 +531%
Marshall Wace
27
Marshall Wace
United Kingdom
$29K +$43.3K +1,679 New
Rockefeller Capital Management
28
Rockefeller Capital Management
New York
$17K – – –
TRCT
29
Tower Research Capital (TRC)
New York
$12K +$11.4K +442 +195%
ACM
30
AIGH Capital Management
Maryland
– -$2.11M -66,469 Closed
WVP
31
Worth Venture Partners
New Jersey
– -$631K -19,878 Closed
VF
32
Virtu Financial
New York
– -$367K -11,547 Closed
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
– -$318K -9,500 Closed
WSFS
34
Wilmington Savings Fund Society
Delaware
– -$298K -9,393 Closed
Northern Trust
35
Northern Trust
Illinois
– -$289K -9,098 Closed
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
– -$251K -7,908 Closed
RAM
37
Redmond Asset Management
Virginia
– -$250K -7,878 Closed
WANY
38
Wealthspire Advisors (New York)
New York
– -$238K -7,500 Closed
VEA
39
Virtus ETF Advisers
New York
– -$76K -2,387 Closed
SWM
40
Spire Wealth Management
Virginia
– -$10K -310 Closed
OSAM
41
O'Shaughnessy Asset Management
Connecticut
– -$1K -32 Closed
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
– +$77 +3 New
Citigroup
43
Citigroup
New York
– +$129 +5 New
FCG
44
Financial Connections Group
California
– +$644 +25 New
1
2

ANVS Hedge Fund Activity: Q4 2021 in Review

32 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q4 2021, worth a combined $19.6M — down 46% from $36.2M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ANVS and 8 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 8 added.

The largest buyer was Morgan Stanley, adding an estimated $3.02M. The largest seller was Voloridge Investment Management, cutting an estimated $2.21M.

  • 32 institutional investors held Annovis Bio (ANVS) as of Q4 2021, down from 38 in Q3 2021.
  • Funds reported $19.6M of Annovis Bio stock for Q4 2021, down 46% quarter-over-quarter.
  • 8 funds opened new Annovis Bio positions in Q4 2021 and 14 closed out, a net change of -6 holders.
  • The largest Annovis Bio buyer in Q4 2021 was Morgan Stanley, an estimated $3.02M added.
  • The largest Annovis Bio seller in Q4 2021 was Voloridge Investment Management, an estimated $2.21M sold.

Based on aggregated 13F filings for Q4 2021.